Global Preventive Asthma Drugs Market 2015-2019 with AstraZeneca, F. Hoffmann-La Roche, GlaxoSmithKline, Merck & Novartis Dominating

23 Oct, 2015, 08:10 ET from Research and Markets

DUBLIN, Oct. 23, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/7ld4g7/global_preventive) has announced the addition of the "Global Preventive Asthma Drugs Market 2015-2019" report to their offering.

The global preventive asthma drugs market to grow at a CAGR of 5.20% over the period 2014-2019.

The report, Global Preventive Asthma Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape of the global preventive asthma drugs market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

According to the Global Initiative for Asthma, asthma is a chronic disease, which is characterized by wheezing, shortness of breath, chest tightness, and cough over a period of time. The symptoms worsen due to the increased secretion of mucus, bronchoconstriction, and thickening of the walls of the airways, resulting in difficulty in expiration.

According to the American Academy of Allergy, Asthma, and Immunology, asthma is classified into four types: exercise-induced, allergic, occupational, and childhood. Also, asthma can be classified into two categories: allergic and non-allergic, as per the classification of Asthma and Allergy Foundation of America. Asthma can be managed by preventive medications, which should be administered to the patient regularly to improve his quality of life by controlling the exacerbations.

This report covers the present scenario and the growth prospects of the global preventive asthma drugs market for 2015-2019.

To calculate the market size, the report considers revenue generated from the sale of the following classes of drugs used to treat asthma:

- Immunosuppressants

- Leukotriene antagonists

- Mast cell stabilizers

- Corticosteroids

- Combination of LABA/ ICS

Key vendors

- AstraZeneca- F. Hoffmann-La Roche- GlaxoSmithKline - Merck- Novartis

Other prominent vendors

- Abbott

- Amgen

- AptarGroup

- Biotest

- Boehringer Ingelheim

- Chiesi Farmaceutici

- Cytos

- Dainippon Sumitomo

- Medicinova

- Mylan

- Novartis

- Orchid Chemicals and Pharmaceuticals

- Pfizer

- Rottapharm Madaus

- Skyepharma

- Sosei

- Sunovion

- Teva Pharmaceutical

- Theravance

- Vectura

For more information visit http://www.researchandmarkets.com/research/7ld4g7/global_preventive

Media Contact:

Laura Wood, +353-1-481-1716, press@researchandmarkets.net

 

SOURCE Research and Markets



RELATED LINKS

http://www.researchandmarkets.com